MOLDTKPAC Q4 FY26 Guidance vs Delivery (MOLDTKPAC Management Mirror)

Overall Revenue & Volumes

Management trimmed its volume growth outlook for the year ending Mar'27 to 10% to 13% in the Mar'26 Qtr, down from the 12% to 15% guidance issued in the Dec'25 Qtr, citing a shift toward high-value, lower-tonnage pharma segments; however, the FY27 top-line value target of crossing INR 1,000 crores with 13% to 15% value growth remains consistent across quarters. [Status: Downgraded]